1. Division of Hematologic Malignancies and Cellular Therapy, Department of Medicine, Duke University School of Medicine, Durham, NC;
2. Duke Cancer Institute, Durham, NC;
3. Department of Medicine, The Warren Alpert Medical School of Brown University, Providence, RI; and
4. Division of Hematology-Oncology, Rhode Island Hospital, Providence, RI